首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Cell chemical biology

缩写:CELL CHEM BIOL

ISSN:2451-9456

e-ISSN:2451-9448

IF/分区:7.2/Q1

文章目录 更多期刊信息

共收录本刊相关文章索引1636
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Apoorva J Pradhan,Daniel Lu,Laura R Parisi et al. Apoorva J Pradhan et al.
Necroptosis is a form of cell death characterized by receptor-interacting protein kinase activity and plasma membrane permeabilization via mixed-lineage kinase-like protein (MLKL). This permeabilization is responsible for the inflammatory p...
Jessica A Cross,Magda S Chegkazi,Roberto A Steiner et al. Jessica A Cross et al.
Synthetic peptides are attractive candidates to manipulate protein-protein interactions inside the cell as they mimic natural interactions to compete for binding. However, protein-peptide interactions are often dynamic and weak. A challenge...
Kusal T G Samarasinghe,Saul Jaime-Figueroa,Michael Burgess et al. Kusal T G Samarasinghe et al.
Many diseases, including cancer, stem from aberrant activation or overexpression of oncoproteins that are associated with multiple signaling pathways. Although proteins with catalytic activity can be successfully drugged, the majority of ot...
Lukas T Henneberg,Brenda A Schulman Lukas T Henneberg
Post-translational modification of proteins by ubiquitin is required for nearly all aspects of eukaryotic cell function. The numerous targets of ubiquitylation, and variety of ubiquitin modifications, are often likened to a code, where the ...
Giulia Martelli,Tomas Bohn Pessatti,Eva Maria Steiner et al. Giulia Martelli et al.
Effective treatment of tuberculosis is frequently hindered by the emerging antimicrobial resistance of Mycobacterium tuberculosis. The present study evaluates monocyclic β-lactam compounds targeting the mycobacterial cell wall remodeling. ...
Martina Zafferani,Amanda E Hargrove Martina Zafferani
Initial successes in developing small molecule ligands for non-coding RNAs have underscored their potential as therapeutic targets. More recently, these successes have been aided by advances in biophysical and structural techniques for iden...
Natalie S Scholes,Cristina Mayor-Ruiz,Georg E Winter Natalie S Scholes
The therapeutic modality of targeted protein degradation promises to overcome limitations of traditional pharmacology. Small-molecule degraders recruit disease-causing proteins to E3 ubiquitin ligases, prompting their ubiquitination and deg...
Yang Zhang,Shuiye Chen,Zhenghong Yuan et al. Yang Zhang et al.
Positive-strand RNA viruses such as hepatitis C virus (HCV), flaviviruses, and coronaviruses are medically important. Assembly of replicase on host membranes is a conserved replication strategy and an attractive antiviral target. The mechan...
Hyelim Cho,Qiong Shen,Lydia H Zhang et al. Hyelim Cho et al.
Three limonoid natural products with selective anti-proliferative activity against BRAF(V600E) and NRAS(Q61K)-mutation-dependent melanoma cell lines were identified. Differential transcriptome analysis revealed dependency of compound activi...
Hannah Kiely-Collins,Georg E Winter,Gonçalo J L Bernardes Hannah Kiely-Collins
Proteolysis-targeting chimeras (PROTACs) that degrade disease-causing proteins by hijacking the endogenous ubiquitin-proteasome system have emerged as an exciting and transformative technology in both chemical biology and drug discovery. Cu...